Patents by Inventor Berend Olivier

Berend Olivier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEROTONERGIC AGENT AND 5-HT1A-RECEPTOR ANTAGONIST
    Publication number: 20220265641
    Abstract: The present disclosure relates to a 5-HT1A-receptor antagonist or a derivative, precursor or metabolite thereof, in combination with at least one serotonergic agent or a derivative, precursor or metabolite thereof for use in the prevention and/or treatment of premature ejaculation, wherein the 5-HT1A-receptor antagonist or a derivative, precursor or metabolite thereof is administered separately, sequentially or simultaneously to the at least one serotonergic agent or a derivative, precursor or metabolite thereof.
    Type: Application
    Filed: July 29, 2020
    Publication date: August 25, 2022
    Inventors: Marcel David Waldinger, Berend Olivier
  • Treatment for a attention-deficit hyperactivity disorder
    Publication number: 20050004105
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans using a 5-HT1A receptor agonist is provided.
    Type: Application
    Filed: January 29, 2004
    Publication date: January 6, 2005
    Inventors: Emer Leahy, Berend Olivier
  • Bibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivatives
    Patent number: 5424313
    Abstract: The invention relates to new compositions with pyschotropic activity which comprise a compound of formula 1 of the formula sheet as the active substance. The compounds of formula 1 are for the greater part new compounds. The invention therefore also relates to these new compounds and to the preparation thereof in a manner known for the synthesis of analogous compounds.
    Type: Grant
    Filed: October 12, 1993
    Date of Patent: June 13, 1995
    Assignee: Duphar International Research B.V.
    Inventors: Jan Hartog, Berend Olivier, Ineke Van Wijngaarden, Cornelis G. Kruse, Johannes A. M. Van Der Heyden, Dirkje A. Van Dalen-Van Der AA
  • 3,4-dehydropiperidine derivatives having psychotropic activity
    Patent number: 5296497
    Abstract: The invention relates to 3,4-dehydropiperidine derivatives having psychotropic activity, which compounds are represented by the general formula 1 ##STR1## wherein R is hydrogen or C.sub.1 -C.sub.3 alkyl;R.sub.2 is hydrogen, an unsubstituted or substituted C.sub.1 -C.sub.10 hydrocarbon group, or a group of the general formula ##STR2## wherein A is C.sub.2 -C.sub.10 alkylene,R.sub.5 is hydrogen or C.sub.1 -C.sub.3 alkyl, andR.sub.6 is unsubstituted or substituted aryl or heteroaryl, hydrocarbon, substituted or unsubstituted (hetero)aralkyl, or substituted or unsubstituted heterocyclic; or wherein R.sub.5 and R.sub.6 together with the carbamoyl group to which they are bound constitute a heterocyclic ring system;n has the value 1 or 2; andZ is a heterocyclic group.
    Type: Grant
    Filed: October 30, 1992
    Date of Patent: March 22, 1994
    Assignee: Duphar International Research B.V.
    Inventors: Jan Hartog, Roelof Van Hes, Berend Olivier, Ineke Van Wijngaarden
  • Method of treating psychotropic conditions employing substituted piperazine compounds
    Patent number: 4782061
    Abstract: The invention relates to a group of new bicyclic heteroarylpiperazine derivatives of formula 1. It was found that these compounds have interesting psychotropic in particular anti-psychotic properties.The compounds can be prepared according to methods known for the synthesis of analogous compounds.
    Type: Grant
    Filed: December 18, 1985
    Date of Patent: November 1, 1988
    Assignee: Duphar International Research B.V.
    Inventors: Cornelis G. Kruse, Johannes A. M. van der Heyden, Ineke van Wijngaarden, Jan Hartog, Berend Olivier